Post by JHam on Jul 20, 2014 17:07:41 GMT
Here is an interview with the CEO where he talks about partnering after Phase. The video is old, made at the beginning of Phase II, but he is very clear in his intent to try and partner after they have collected Phase II data. This video was likely made before ONCS realized the potential of ImmunoPulse when used as a combined therapy. So maybe the strategy has changed. Instead of trying to partner out ImmunoPulse as a mono therapy, they may rather wait to have a partner for both mono and combined therapies (i.e., waiting until Phase IIb launching or until some data is collected).
It's only a 2:30 video, but skip to 1:40 if you want to hear about the partnering talk.
m.youtube.com/watch?feature=share&v=064JL6mWlzs
Phase II for Metastatic Melanoma is complete and they could present that data any time. They already presented "near final data" a few months ago.
It's only a 2:30 video, but skip to 1:40 if you want to hear about the partnering talk.
m.youtube.com/watch?feature=share&v=064JL6mWlzs
Phase II for Metastatic Melanoma is complete and they could present that data any time. They already presented "near final data" a few months ago.